Valentino D'onofrio

Gent, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Queer Science and Scientists Are Shaping the Future of Immunology.

Queer Science and Scientists Are Shaping the Future of Immunology.

Journal: European journal of immunology

Published: May 05, 2026

A first-in-human Phase 1/1b randomized trial evaluating the safety and immunogenicity of a respiratory syncytial virus (RSV) virus-like particle subunit vaccine (IVX-121) in healthy young and older adults.

A first-in-human Phase 1/1b randomized trial evaluating the safety and immunogenicity of a respiratory syncytial virus (RSV) virus-like particle subunit vaccine (IVX-121) in healthy young and older adults.

Journal: Human vaccines & immunotherapeutics

Published: March 03, 2026

A unified network systems approach uncovers a core program underlying T follicular helper cell differentiation.

A unified network systems approach uncovers a core program underlying T follicular helper cell differentiation.

Journal: Nature communications

Published: February 22, 2026

Cytokine dynamics following initiation of gender-affirming hormone therapy in transgender subjects.

Cytokine dynamics following initiation of gender-affirming hormone therapy in transgender subjects.

Journal: The Journal of clinical endocrinology and metabolism

Published: January 20, 2026

A unified network systems approach uncovers a core novel program underlying T follicular helper cell differentiation.

A unified network systems approach uncovers a core novel program underlying T follicular helper cell differentiation.

Journal: bioRxiv : the preprint server for biology

Published: September 02, 2025

A Novel Carbohydrate Fatty-Acid Monosulphate Ester, Squalane-in-Water Adjuvant Is Safe and Enhances Inactivated Influenza Vaccine Immunogenicity in Older Adults.

A Novel Carbohydrate Fatty-Acid Monosulphate Ester, Squalane-in-Water Adjuvant Is Safe and Enhances Inactivated Influenza Vaccine Immunogenicity in Older Adults.

Journal: Vaccines

Published: July 28, 2025

AS04 drives superior cross-protective antibody response by increased NOTCH signaling of dendritic cells and proliferation of memory B cells.

AS04 drives superior cross-protective antibody response by increased NOTCH signaling of dendritic cells and proliferation of memory B cells.

Journal: Frontiers in immunology

Published: May 05, 2025

Synthetic plasma pool cohort correction for affinity-based proteomics datasets allows multiple study comparison.

Synthetic plasma pool cohort correction for affinity-based proteomics datasets allows multiple study comparison.

Journal: Briefings in bioinformatics

Published: August 30, 2024

The immune-endocrine interplay in sex differential responses to viral infection and COVID-19.

The immune-endocrine interplay in sex differential responses to viral infection and COVID-19.

Journal: Trends in immunology

Published: August 21, 2024

Safety and Immunogenicity of a Carbohydrate Fatty Acid Monosulphate Ester Adjuvant Combined with a Low-Dose Quadrivalent Split-Virion Inactivated Influenza Vaccine: A Randomised, Observer-Blind, Active-Controlled, First-in-Human, Phase 1 Study.

Safety and Immunogenicity of a Carbohydrate Fatty Acid Monosulphate Ester Adjuvant Combined with a Low-Dose Quadrivalent Split-Virion Inactivated Influenza Vaccine: A Randomised, Observer-Blind, Active-Controlled, First-in-Human, Phase 1 Study.

Journal: Vaccines

Published: July 19, 2024

Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults: a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trial.

Safety and immunogenicity of the live-attenuated hRVFV-4s vaccine against Rift Valley fever in healthy adults: a dose-escalation, placebo-controlled, first-in-human, phase 1 randomised clinical trial.

Journal: The Lancet. Infectious diseases

Published: April 24, 2024

Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults: The IMCOVAS randomized clinical trial.

Humoral immune response against SARS-CoV-2 after adapted COVID-19 vaccine schedules in healthy adults: The IMCOVAS randomized clinical trial.

Journal: Vaccine

Published: February 01, 2024

Showing 1-12 of 29

Last Updated: 09/26/2026